Populus Media, the leader in virtual care media solutions, announced the positioning of its Custom Connect service as the first virtual patient acquisition platform, allowing pharmaceutical companies to realize immediate script lift ROI from their existing digital media campaigns.

The company’s Custom Connect platform allows pharmaceutical brands to immediately realize revenue through prescriptions by leveraging their existing digital media platforms and connecting patients with physicians at the click of a banner or other call to action.

Marketing Technology News: OneTrust is “Leading the Market Outright” and Ranked #1 in Market Share for Privacy Software

The ability to eliminate the guesswork required to drive a patient from a media asset to an HCP is transformative in the industry and drastically reduces the amount of effort and budget required to drive that conversation and it dramatically increases ROI.

“It’s important that companies have realized that Custom Connect is about direct virtual patient acquisition and that it’s not a media campaign,” said Howard Seidman, the company’s COO. “We are providing a vehicle to connect an interested consumer directly from a digital ad or part of an existing media buy to an HCP for a consult and prescription. No one else in the market is doing this at scale.”

Marketing Technology News: MarTech Interview with Paul Biggs, Director of Product Marketing at Contentful

Populus Media has demonstrated significant success with their clients, who have case studies showing that up to 75% of patients who click on an ad become qualified for the consult, and the majority of those patients have been prescribed the client medication when medically appropriate.

Populus has seen tremendous growth over the past 12 months, working with over 36 clients such as Evofem Biosciences and Bausch Health. Populus made history as the first company to provide media buying opportunities within the telehealth consultation environment. Custom Connect takes their leadership in the telehealth media industry one step further by connecting patients directly to prescriptions for branded pharma products.

The company has also announced that its other existing media offerings are being enhanced through a new offering called PatientAccess, which follows the patient post consult and ensures media views through follow-up communications with patients.